PARDES BIOSCIENCES, INC.

CA

Developing oral anti-virals for COVID-19 and other Pan-coronaviruses.

Filings
7
Firms Hired
1
Total Expenses
$720,000
Years Active
2022–2023

Filings

All 20232022
YearFirmPeriodExpensesDoc
2023 PARDES BIOSCIENCES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination 		$120,000
2023 PARDES BIOSCIENCES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$120,000
Firms Hired
FirmFilingsExpenses
PARDES BIOSCIENCES, INC. 7 $720,000
Issue Areas
IssueActivities
Health Issues 7
Medicare/Medicaid 7
Pharmacy 7
Medical/Disease Research/Clinical Labs 7